Cara Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Good afternoon. My name is Daniel Wolle. I'm one of the associates on the biotech team. We're continuing the 2020 Healthcare -- the JPM Healthcare with Cara Therapeutics. After their presentation, the breakout sessions will be held in the Olympic Room. Before that though, I present Derek Chalmers, CEO of Cara Therapeutics.
Great. Thank you, Daniel. Good afternoon, everybody. Thanks for staying late this afternoon. So what I'm going to do this morning -- I'm sorry, this afternoon, is run through our basic therapeutic focus very briefly, then update you on our various clinical programs and our advancement there through last year and what we expect this year and then finish with the major milestones for the year. Of course, there will be some forward-looking statements.
So Cara today is a company focused on developing a novel therapeutic approach for the treatment of chronic systemic pruritus. And I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
